Cargando…
The Overexpression of SLC25A13 Predicts Poor Prognosis and Is Correlated with Immune Cell Infiltration in Patients with Skin Cutaneous Melanoma
PURPOSE: Skin cutaneous melanoma (SKCM) is one of the most malignant and aggressive cancers with poor prognosis due to its rapid progression towards metastasis. Thus, finding clinically relevant biomarkers for early diagnosis, prognosis, and therapy prediction is essential. This study focused on the...
Autores principales: | lv, Yue, Yuan, Chun-hui, Han, Lu-yao, Huang, Gao-ru, Ju, Ling-ce, Chen, Ling-hui, Han, Hai-ying, Zhang, Chong, Zeng, Ling-hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124094/ https://www.ncbi.nlm.nih.gov/pubmed/35607442 http://dx.doi.org/10.1155/2022/4091978 |
Ejemplares similares
-
TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM)
por: Zhou, Sitong, et al.
Publicado: (2022) -
SKA3 overexpression predicts poor outcomes in skin cutaneous melanoma patients
por: Pang, Hao, et al.
Publicado: (2021) -
The role of SRGN in the survival and immune infiltrates of skin cutaneous melanoma (SKCM) and SKCM-metastasis patients
por: Wang, Xiaofang, et al.
Publicado: (2020) -
Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020) -
Overexpression of RACK1 Predicts Poor Prognosis in Melanoma
por: Shen, Congcong, et al.
Publicado: (2020)